Yi-Da Tang Selected Research

Myocardial Ischemia (Ischemic Heart Diseases)

1/2022	Assessment of causal direction between thyroid function and cardiometabolic health: a Mendelian randomization study.
1/2022	Isoform-Selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury Via Mitochondrial Protection Through the HDACs/CREB/PGC-1α Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Da Tang Research Topics

Disease

18	Myocardial Infarction 06/2022 - 02/2003
9	Heart Failure 03/2024 - 12/2009
8	Non-alcoholic Fatty Liver Disease 10/2023 - 12/2017
8	Fibrosis (Cirrhosis) 12/2022 - 12/2016
7	Inflammation (Inflammations) 01/2022 - 12/2009
6	Hypothyroidism 03/2024 - 11/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2023 - 01/2021
6	Atrial Fibrillation 08/2022 - 06/2020
5	Insulin Resistance 03/2023 - 01/2018
5	Death (Near-Death Experience) 01/2022 - 11/2014
4	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 06/2023 - 01/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2023 - 01/2022
3	Hemorrhage 06/2022 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2022
3	Infarction (Infarctions) 12/2019 - 02/2003
3	Thrombosis (Thrombus) 07/2018 - 12/2009
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2023 - 12/2022
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2023 - 01/2020
2	Acute Coronary Syndrome 06/2022 - 09/2007
2	Chronic Renal Insufficiency 06/2022 - 07/2021
2	ST Elevation Myocardial Infarction 06/2022 - 01/2020
2	Stroke (Strokes) 01/2022 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2022
2	Ventricular Remodeling 01/2022 - 02/2003
2	Hypoxia (Hypoxemia) 01/2022 - 12/2018
2	Hyperthyroidism 01/2022 - 01/2022
2	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2012
2	Reperfusion Injury 01/2022 - 12/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2022
2	Left Ventricular Dysfunction 11/2020 - 06/2020
2	Cardiac Arrhythmias (Arrythmia) 06/2020 - 01/2018
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2018 - 12/2016
1	Thyroid Diseases (Thyroid Disease) 01/2023
1	Surgical Wound 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Hyperglycemia 01/2023
1	Aortic Valve Insufficiency (Aortic Regurgitation) 10/2022
1	Ischemic Stroke 06/2022
1	Essential Hypertension 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Pulmonary Heart Disease (Cor Pulmonale) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Airway Obstruction (Choking) 01/2022
1	Obesity 01/2022

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 01/2022 - 01/2012
8	omega-Chloroacetophenone (Mace)IBA 01/2022 - 03/2015
7	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2021 - 12/2016
5	Triglycerides (Triacylglycerol)IBA 06/2023 - 01/2022
4	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 01/2018
4	Thyroid HormonesIBA 01/2023 - 01/2018
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2022 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2009
3	C-Reactive ProteinIBA 01/2022 - 12/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2009
2	Thyroxine (Levothyroxine)FDA LinkGeneric 03/2024 - 12/2005
2	Alanine Transaminase (SGPT)IBA 09/2023 - 12/2022
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2023 - 12/2022
2	Indicators and Reagents (Reagents)IBA 08/2022 - 01/2022
2	CholesterolIBA 01/2022 - 12/2021
2	CreatinineIBA 10/2021 - 04/2021
2	Lipoprotein(a)IBA 03/2020 - 01/2020
2	CalciumIBA 12/2019 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 12/2019 - 02/2003
2	Clopidogrel (Plavix)FDA Link 01/2018 - 12/2009
2	GadoliniumIBA 01/2018 - 12/2016
2	Therapeutic UsesIBA 12/2017 - 01/2011
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2012 - 01/2011
2	Erythropoietin FDA Link 12/2009 - 09/2007
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 09/2023
1	LDL CholesterolIBA 03/2023
1	Insulin (Novolin)FDA Link 03/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2023
1	N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2022
1	AnticoagulantsIBA 06/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2022
1	Angiotensin Receptor AntagonistsIBA 06/2022
1	1- ethynyl- 4- hydroperoxy- 1,2,3,4- tetrahydro- 1- naphtholIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	mocetinostatIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022

Therapy/Procedure

12	Therapeutics 07/2023 - 01/2011
10	Percutaneous Coronary Intervention 06/2022 - 01/2018
2	Patient Readmission 01/2023 - 01/2023
2	Conservative Treatment 04/2021 - 01/2020
2	Stents 07/2018 - 11/2014
1	Drug Therapy (Chemotherapy) 10/2023
1	Sternotomy 01/2023
1	Molecular Targeted Therapy 01/2023
1	Transcatheter Aortic Valve Replacement 10/2022
1	Intraperitoneal Injections 01/2022